| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |